The most popular content this past month included the release of the list of ACC 2021 late-breaking studies, the first AF patients treated with a new pulsed field ablation system, a blog on how the recently FDA cleared coronary lithotripsy balloon system may become a paradigm shift in the cath lab, and the development of engineered tissue valves that can grow with younger patients. 
Feature | By Dave Fornell, Editor
Most Popular Cardiology Technology Content in March 2021

April 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home April 01, 2021
Home
Videos | Cath Lab
VIDEO: Example of Coronary Lithotripsy to Break up Calcified Lesion

This is a quick example of clinical use of the Shockwave Medical Intravascular Lithotripsy system that uses sonic wave ...

Home March 31, 2021
Home
Researchers found a relationship between stress-associated neurobiological activity on 18F-FDG PET-CT imaging and risk for subsequent Takotsubo syndrome impacting the heart.
News
PET-CT Shows Stressed Brain Linked to Broken Heart

March 31, 2021 — Heightened activity in the brain, caused by stressful events, is linked to the risk of developing a ...

Home March 31, 2021
Home
cImage Inc. celebrates its cloud partnership with Digirad Health after a year of successful deployment of PICOM365 for mobile imaging. Digirad’s fleet of mobile SPECT, echocardiology, vascular and general ultrasound units combined with PICOM365’s cloud image management workflow leverage each company’s strengths to create an exemplary reading and reporting environment.
News | Cardiac Imaging
ScImage Cloud Partnership With Digirad Aids Flow of Nuclear and Echo Imaging

March 31, 2021 — ScImage Inc. celebrates its cloud partnership with Digirad Health after a year of successful deployment ...

Home March 31, 2021
Home
Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound (POCUS), GE Healthcare unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first artificial intelligence (AI) offering for cardiac imaging on the Venue and Venue Go. The Venue Fit is the smallest system in GE Healthcare’s Venue Family, featuring an easy-to-clean touchscreen, intuitive scanning tools, and a small footprint designed to fit in tight spaces often found in point-of
News | Point-of-Care Ultrasound (POCUS)
GE Healthcare Expands Ultrasound Family with New Point of Care System and AI Offering

March 31, 2021 — Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound ...

Home March 31, 2021
Home
The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System. It is first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT) to stop severe pulmonary valve regurgitation caused by congenital heart disease.
Feature | Structural Heart | By Dave Fornell, Editor
FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease

March 26, 2021 — Today, the U.S. Food and Drug Administration (FDA) cleared the Medtronic Harmony Transcatheter ...

Home March 26, 2021
Home
The March April 2021 issue of DAIC, Diagnostic and Interventional Cardiology magazine, Dave Fornell is the editor.
Feature
The DAIC March-April 2021 Digital Edition

View the March-April 2021 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, including links ...

Home March 26, 2021
Home
Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell
Feature
Virtual Tours of Cath and EP Labs

There is a lot of interest in how other hospitals organize and equip their cardiac cath labs and electrophysiology (EP) ...

Home March 25, 2021
Home
Neonates and young pediatric patients with congenital heart disease have few options for implantable electrophysiology (EP) devices like pacemakers or ICDs.
News | Congenital Heart
Critical Need for Pediatric Electrophysiology Devices is Focus of Medical Device Competition 

March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often ...

Home March 24, 2021
Home
PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.
News | Heart Failure
100th Patient Implanted With Cordella Pulmonary Artery Pressure Sensor For Proactive, Remote Heart Failure Management

March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating of ...

Home March 24, 2021
Home
Videos | Structural Heart
VIDEO: PFO Closure Shows Continued Stroke Prevention Benefit at 5 Years

Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial, and ...

Home March 23, 2021
Home
Top left, electromechanical wave imaging (EWI) isochrone renderings showing the activation points of the myocardium based on echocardiography axial strain measurements. Bottom right, EWI images overlaid on patient's CT scan of the heart.
News | EP Lab
New Ultrasound Technique Helps Pinpoint Source of Arrhythmias

March 23, 2021 — Researchers at Columbia University are using cardiac ultrasound to improve the critical need to ...

Home March 23, 2021
Home
Early detection of high-risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics. The company Elucid has developed AI to identify these atherosclerotic plaque phenotypes from a CT scan.
News | CT Angiography (CTA)
Study Demonstrates AI Can Estimate RNA Expression From Cardiac CT Scan

March 23, 2021 — Researchers at the Karolinska Institute in Stockholm, Sweden, have published the first-of-its-kind ...

Home March 23, 2021
Home
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor
Overview of Trials for Anticoagulation Therapy for COVID-19 Patients

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...

Home March 22, 2021
Home
Videos | Ventricular Assist Devices (VAD)
VIDEO: New LVAD Designed to Prevent Hemolysis and Clots

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

Home March 22, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now